Beijing, China

Xin Gong

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Sammamish, WA (US) (2018)
  • Issaquah, WA (US) (2018)
  • Beijing, CN (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Inventor Xin Gong

Introduction

Xin Gong is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant fusion proteins. With a total of five patents to his name, his work has the potential to impact vaccine development and antibody preparation.

Latest Patents

One of Xin Gong's latest patents is a method for preparing bacterial polysaccharide-modified recombinant fusion protein and its use. This invention provides a method for co-expressing a recombinant fusion protein and the O-oligosaccharyltransferase PglL in an O-antigen ligase gene-defective bacterium. The process links polysaccharides, either endogenous or exogenous to the bacterium, to the recombinant fusion protein, resulting in a bacterial polysaccharide-modified recombinant fusion protein. This protein can be utilized for preparing antibodies against bacterial polysaccharides and vaccines. Another notable patent involves an O-antigen with an extended carbohydrate chain and its applications. This method includes inactivating a gene that controls the chain length of the O-antigen, allowing for the overexpression of another gene to extend the carbohydrate chain length. The resulting O-polysaccharide-recombinant fusion protein conjugate vaccines can induce specific antibody generation in mice, significantly improving antibody titers.

Career Highlights

Xin Gong has worked with notable organizations such as Microsoft Technology Licensing, LLC and the Institute of Biotechnology at the Academy of Military Medical Sciences in China. His experience in these institutions has contributed to his expertise in biotechnology and patent development.

Collaborations

Some of his coworkers include Jun Wu and Chao Pan, who have collaborated with him on various projects in the field of biotechnology.

Conclusion

Xin Gong's innovative work in recombinant fusion proteins and vaccine development showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing medical science and improving public health through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…